|December 2012 Research Spotlight: Dr. Yan Sanders|
Dr. Yan Sanders' paper entitled "Altered DNA methylation profile in idiopathic pulmonary fibrosis", published in the American Journal of Respiratory & Critical Care Medicine, has been selected as the Department of Medicine's paper of the month for December 2012.
Dr. Yan Sanders received her M.D. from Hunan Medical University, China, and M.S. in Pathology from University of Arkansas for Medical Sciences. She completed a postdoctoral research fellowship at the National Center for Toxicological Research before she joined UAB. She is currently an assistant professor in the Division of Pulmonary, Allergy and Critical Medicine.
Dr. Sanders' main research interests are on the epigenetics aspects of pulmonary fibrosis, mainly the roles of histone modifications and DNA methylation in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Her research projects include examining the effects of histone modifiers on fibrotic lung fibroblasts and determining the epigenetic alterations in idiopathic pulmonary fibrosis (IPF) fibrotic foci. Current work has been focused on exploring the epigenetic mechanisms of aging in the pathogenesis of IPF.
Am J Respir Crit Care Med. 2012 Sep 15;186(6):525-35. doi: 10.1164/rccm.201201-0077OC. Epub 2012 Jun 14.
DNA methylation is an important epigenetic mechanism, which often occurs in response to environmental stimuli and is crucial in regulating gene expression. It is likely that epigenetic alterations contribute to pathogenesis in idiopathic pulmonary fibrosis (IPF).
To determine the DNA methylation changes in IPF and their effects on gene expression.
Total DNA methylation and DNA methyltransferase expression were compared in IPF and normal control lung tissues. IPF and normal tissues were subjected to comparative analysis of genome-wide DNA methylation and RNA expression using DNA hybridization to the Illumina HumanMethylation27 BeadChip and RNA hybridization to Illumina HumanHT-12 BeadChip. Functional analyses of differentially expressed and differentially methylated genes were done. Selected genes were validated at DNA, RNA, and protein levels.
MEASUREMENTS AND MAIN RESULTS:
DNA methylation status was altered in IPF. IPF samples demonstrated higher DNA methyltransferase expression without observed alterations in global DNA methylation. Genome-wide differences in DNA methylation status and RNA expression were demonstrated by array hybridization. Among the genes whose DNA methylation status and RNA expression were both significantly altered, 16 genes were hypermethylated in DNA associated with decreased mRNA expression or vice versa. We validated CLDN5, ZNF467, TP53INP1, and DDAH1 genes at the level of DNA methylation status, RNA, and protein-level expression.
Changes in DNA methylation correspond to altered mRNA expression of a number of genes, some with known and others with previously uncharacterized roles in IPF, suggesting that DNA methylation is important in the pathogenesis of IPF.